Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

A Look Into Healthcare Sector Value Stocks

Author: Benzinga Insights | December 11, 2023 10:43am

Understanding Value Stocks

A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued.

The following stocks are considered to be notable value stocks in the healthcare sector:

  1. Cross Country Healthcare (NASDAQ:CCRN) - P/E: 7.23
  2. Nuwellis (NASDAQ:NUWE) - P/E: 0.02
  3. First Wave BioPharma (NASDAQ:FWBI) - P/E: 0.01
  4. Voyager Therapeutics (NASDAQ:VYGR) - P/E: 6.69
  5. Panbela Therapeutics (NASDAQ:PBLA) - P/E: 0.0

Most recently, Cross Country Healthcare reported earnings per share at $0.39, whereas in Q2 earnings per share sat at $0.69. Nuwellis's earnings per share for Q3 sits at $-1.81, whereas in Q2, they were at -3.65. First Wave BioPharma's earnings per share for Q3 sits at $-0.46, whereas in Q2, they were at -1.89. Voyager Therapeutics's earnings per share for Q3 sits at $-0.59, whereas in Q2, they were at -0.51. Panbela Therapeutics saw an increase in earnings per share from -7.95 in Q2 to $-2.42 now.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Posted In: CCRN FWBI NUWE PBLA VYGR